ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Junchao Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6759-5147; OpenAlex author ID A5107975982. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2021: 1 paper

Papers 1

Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transforming growth factor-β receptors in patients… Last author DOI 10.1111/jgh.15244 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bolun Jiang · 1 shared paper, 2021 · strength 0.13
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244 ↗
Li Zhou · 1 shared paper, 2021 · strength 0.13
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244 ↗
Jun Lü · 1 shared paper, 2021 · strength 0.13
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244 ↗
Yizhi Wang · 1 shared paper, 2021 · strength 0.13
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244 ↗
Zhiyong Liang · 1 shared paper, 2021 · strength 0.13
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244 ↗
Lei You · 1 shared paper, 2021 · strength 0.13
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.